SCHEMBL8339659

SCHEMBL8339659

COC(=O)c1sc(-c2ccccc2)nc1C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.73
SMN1; SMN2 Q16637 6/20 0.71
ALDH1A1 P00352 6/20 0.70
HPGD P15428 4/20 0.70
NPSR1 Q6W5P4 1/20 0.70
MAPT P10636 6/20 0.67
GAA P10253 2/20 0.67
NPC1 O15118 6/20 0.63
RAB9A P51151 7/20 0.61
KMT2A Q03164 5/20 0.58
LMNA P02545 2/20 0.58
ATM Q13315 1/20 0.58
MEN1 O00255 4/20 0.58
L3MBTL1 Q9Y468 1/20 0.57
KDM4E B2RXH2 1/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
CYP3A4 P08684 1/20 0.56
RECQL P46063 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12402761 0.88 RAB9A (0.69) TRPM8SMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL28931086 0.86 TRPM8 (0.58) TRPM8SMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL8345120 0.85 MAPT (0.57) TRPM8SMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL8339292 0.85 SMN1; SMN2 (0.72) TRPM8SMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL1316281 0.85 CDC7 (0.77) TRPM8SMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL15048954 0.84 TRPM8 (1.00) TRPM8SMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL974923 0.84 TRPM8 (0.73) TRPM8SMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL16312760 0.84 SMN1; SMN2 (0.66) TRPM8SMN1; SMN2ALDH1A1HPGDNPSR1
SCHEMBL1327631 0.83 SMN1; SMN2 (1.00) SMN1; SMN2ALDH1A1HPGDNPSR1MAPT
Methane SCHEMBL9629328 0.83 TRPM8 (0.97) TRPM8SMN1; SMN2ALDH1A1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110184186-A1 PROCESS FOR PREPARING LIGANDS OF PPARDELTA AND THE INTERMEDIATE COMPOUNDS FOR PREPARING THE SAME SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2011-07-28 US disclosed
US-7982050-B2 Process for preparing ligands of PPARdelta and the intermediate compounds for preparing the same SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2011-07-19 US disclosed
US-20090118516-A1 Process for preparing ligands of ppardelta and the intermediate compounds for preparing the same Kang, Heon Joong (KR) 2009-05-07 US disclosed
US-20070179300-A1 Process for preparing thiazole derivative and the intermediate compounds for preparing the same SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2007-08-02 US disclosed
US-7241901-B2 Process for preparing thiazole derivative and the intermediate compounds for preparing the same SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2007-07-10 US disclosed
US-5888941-A Carbozamides with antifungal activity J. URIACH & CIA. S.A. (ES) 1999-03-30 US disclosed
EP-0783502-A1 NEW CARBOXAMIDES WITH ANTIFUNGAL ACTIVITY J. URIACH & CIA. S.A. (ES) 1997-07-16 EP disclosed
WO-1997005131-A1 NEW CARBOXAMIDES WITH ANTIFUNGAL ACTIVITY J. URIACH & CIA. S.A. (ES) 1997-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179300-A1 Process for preparing thiazole derivative and the intermediate compounds for preparing the same PPARD, PPARG, PPARA TRPM8 1841/4885SMN1; SMN2 4743/4885ALDH1A1 816/4885
US-20110184186-A1 PROCESS FOR PREPARING LIGANDS OF PPARDELTA AND THE INTERMEDIATE COMPOUNDS FOR PREPARING THE SAME PPARG, PPARD, PPARA TRPM8 2785/4885SMN1; SMN2 4828/4885ALDH1A1 1346/4885
US-20090118516-A1 Process for preparing ligands of ppardelta and the intermediate compounds for preparing the same PPARG, PPARD, PPARA TRPM8 2785/4885SMN1; SMN2 4828/4885ALDH1A1 1346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.